Neomycin
174 brands · 87 companies · product forms
Opportunity snapshot
Who competes here
Top companies by brand count — fragmented market (no dominant player) · leader share 6%
Price room
max/min price ratio 109.74x across 50 trusted points (Rs 20.37-2235.5). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.
Brands & products on the market
Sample of 12 live products for Neomycin — each links to its own medicine page.
Regulatory alerts
Why this score
Launch attractiveness
40% supply-gap(20) + 25% price-variation(100) + 20% low-competition(0) + 15% supply-disruption(40), damped by confidence(90). Higher = more attractive, less crowded opportunity.
Market saturation
87 canonical companies and 174 brands compete (saturation pegged at 30 companies / 150 brands).
Price room
max/min price ratio 109.74x across 50 trusted points (Rs 20.37-2235.5). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.
Regulatory risk
1 DRAP alert(s), latest 2025-10-24 incl. recall/safety.
Confidence
Reduced by: no ATC code.
Packaged brief for this moderate opportunity?
Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.
See packaged reports All 3868 molecules